Iterum Therapeutics PLC ITRMF
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow ITRMF
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
472.61% | 518.47% | 325.35% | 285.48% | |
| (69.93%) | (85.79%) | (99.93%) | (111.35%) | ||
ROIC |
0.00% | (184.61%) | (297.39%) | (455.51%) | |
Return on Tangible Assets |
(343.84%) | (227.85%) | (256.98%) | (368.57%) | |
Average Days of Receivables |
0.00 | — | — | 177.74 | |
Free Cash Flow per Share |
(1.36) | (0.49) | (0.37) | (0.43) | |
Free Cash Flow |
(26.77) | (16.75) | (14.74) | (19.53) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | (0.01) | |
Piotroski F-Score |
— | 1.00 | 1.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(66.35%) | (54.37%) | (49.47%) | (78.57%) | |
Accounts Receivable Turnover |
0.00 | — | — | 3.79 | |
Accounts Payable Turnover |
0.00 | 0.98 | 1.55 | 1.62 | |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 91.25 | 278.02 | 184.26 | |
Days of Inventory on Hand |
— | 117.76 | 221.67 | 366.92 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 451.20% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 1,692.28% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 28.15% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.08 | 0.74 | 0.61 | 0.72 | |
Depreciation/Fixed assets |
111.83 | 141.06 | 192.75 | 115.83 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.01) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.02 | |
Operating CF per Share |
(1.36) | (0.49) | (0.37) | (0.43) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.02 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (2,930.54%) |
Columns are period end dates